Cargando…
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study
BACKGROUND: Despite its increasing prevalence and acceptance among the general public, cannabis use continues to be viewed as an aberrant activity in many contexts. However, little is known about how stigma associated with cannabis use affects individuals who use cannabis for therapeutic purposes (C...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/ https://www.ncbi.nlm.nih.gov/pubmed/23414118 http://dx.doi.org/10.1186/1477-7517-10-2 |
_version_ | 1782261087351078912 |
---|---|
author | Bottorff, Joan L Bissell, Laura JL Balneaves, Lynda G Oliffe, John L Capler, N Rielle Buxton, Jane |
author_facet | Bottorff, Joan L Bissell, Laura JL Balneaves, Lynda G Oliffe, John L Capler, N Rielle Buxton, Jane |
author_sort | Bottorff, Joan L |
collection | PubMed |
description | BACKGROUND: Despite its increasing prevalence and acceptance among the general public, cannabis use continues to be viewed as an aberrant activity in many contexts. However, little is known about how stigma associated with cannabis use affects individuals who use cannabis for therapeutic purposes (CTP) and what strategies these individuals employ to manage associated stigma. The aim of this Canadian study was to describe users’ perceptions of and responses to the stigma attached to using CTP. METHODS: Twenty-three individuals who were using CTP for a range of health problems took part in semi-structured interviews. Transcribed data were analyzed using an inductive approach and comparative strategies to explore participants’ perceptions of CTP and identify themes. RESULTS: Participant experiences of stigma were related to negative views of cannabis as a recreational drug, the current criminal sanctions associated with cannabis use, and using cannabis in the context of stigmatizing vulnerability (related to existing illness and disability). Strategies for managing the resulting stigma of using CTP included: keeping CTP ‘undercover’; educating those who did not approve of or understand CTP use; and using cannabis responsibly. CONCLUSIONS: Understanding how individuals perceive and respond to stigma can inform the development of strategies aimed at reducing stigma associated with the use of CTP and thereby address barriers faced by those using this medicine. |
format | Online Article Text |
id | pubmed-3584982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35849822013-03-02 Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study Bottorff, Joan L Bissell, Laura JL Balneaves, Lynda G Oliffe, John L Capler, N Rielle Buxton, Jane Harm Reduct J Research BACKGROUND: Despite its increasing prevalence and acceptance among the general public, cannabis use continues to be viewed as an aberrant activity in many contexts. However, little is known about how stigma associated with cannabis use affects individuals who use cannabis for therapeutic purposes (CTP) and what strategies these individuals employ to manage associated stigma. The aim of this Canadian study was to describe users’ perceptions of and responses to the stigma attached to using CTP. METHODS: Twenty-three individuals who were using CTP for a range of health problems took part in semi-structured interviews. Transcribed data were analyzed using an inductive approach and comparative strategies to explore participants’ perceptions of CTP and identify themes. RESULTS: Participant experiences of stigma were related to negative views of cannabis as a recreational drug, the current criminal sanctions associated with cannabis use, and using cannabis in the context of stigmatizing vulnerability (related to existing illness and disability). Strategies for managing the resulting stigma of using CTP included: keeping CTP ‘undercover’; educating those who did not approve of or understand CTP use; and using cannabis responsibly. CONCLUSIONS: Understanding how individuals perceive and respond to stigma can inform the development of strategies aimed at reducing stigma associated with the use of CTP and thereby address barriers faced by those using this medicine. BioMed Central 2013-02-16 /pmc/articles/PMC3584982/ /pubmed/23414118 http://dx.doi.org/10.1186/1477-7517-10-2 Text en Copyright ©2013 Bottorff et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Bottorff, Joan L Bissell, Laura JL Balneaves, Lynda G Oliffe, John L Capler, N Rielle Buxton, Jane Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study |
title | Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study |
title_full | Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study |
title_fullStr | Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study |
title_full_unstemmed | Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study |
title_short | Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study |
title_sort | perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/ https://www.ncbi.nlm.nih.gov/pubmed/23414118 http://dx.doi.org/10.1186/1477-7517-10-2 |
work_keys_str_mv | AT bottorffjoanl perceptionsofcannabisasastigmatizedmedicineaqualitativedescriptivestudy AT bisselllaurajl perceptionsofcannabisasastigmatizedmedicineaqualitativedescriptivestudy AT balneaveslyndag perceptionsofcannabisasastigmatizedmedicineaqualitativedescriptivestudy AT oliffejohnl perceptionsofcannabisasastigmatizedmedicineaqualitativedescriptivestudy AT caplernrielle perceptionsofcannabisasastigmatizedmedicineaqualitativedescriptivestudy AT buxtonjane perceptionsofcannabisasastigmatizedmedicineaqualitativedescriptivestudy |